Showing results (31-40 of 424) with videos related to
Sort By:
Pageof 43
Blood|August 1, 1995
Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWFL Hilbert, C Gaucher, C MazurierBritish Journal of Haematology|December 1, 1995
Effects of different amino-acid substitutions in the leucine 694-proline 708 segment of recombinant von Willebrand factorL Hilbert, C Gaucher, C MazurierThe Journal of Biological Chemistry|June 24, 1994
Assembly of amino-terminal fibronectin dimers into the extracellular matrixJ Sottile, S WileyThrombosis and Haemostasis|February 12, 1998
Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutationsC de Romeuf, L Hilbert, C MazurierPlant Physiology|November 1, 1991
Ectomycorrhizin Synthesis and Polypeptide Changes during the Early Stage of Eucalypt Mycorrhiza DevelopmentJ L Hilbert, G Costa, F MartinInternational Immunology|November 29, 2002
Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptorsRonald Sluyter, James S WileyMolecular and Cellular Biochemistry|March 8, 2000
Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosisB Formby, T S WileyAnnals of Clinical and Laboratory Science|December 10, 1998
Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53B Formby, T S WileyAnalytical Biochemistry|December 28, 1999
Ratiometric assay of epidermal growth factor receptor tyrosine kinase activationK Schooler, H S WileyEvolution, Medicine, and Public Health|February 14, 2022
How a pregnant woman's relationships with her siblings relate to her mental health: a prenatal allocare perspectiveMolly Fox, Kyle S WileyPageof 43